Département de médecine de laboratoire, Service clinique d'anatomopathologie, Université Laval, Québec, Canada.
Joint Department of Medical Imaging, University Health Network, University of Toronto, Toronto, ON, Canada.
Pathology. 2021 Jan;53(1):3-11. doi: 10.1016/j.pathol.2020.09.016. Epub 2020 Nov 2.
Since the conception of the Gleason grading system, several modifications have been made, including the definition of Gleason pattern 5 (GP5) and its reporting in biopsies and prostatectomy specimens. This includes the addition of a few GP5 sub-patterns over time such as single file, solid cylinders and pseudorosetting. Comedonecrosis was also adopted as a GP5 pattern, but in 2014 the International Society of Urological Pathology (ISUP) excluded intraductal carcinoma with comedonecrosis from the GP5 sub-patterns, although the vast majority of cases with comedonecrosis actually represent intraductal carcinoma. The 2019 conference on prostate cancer grading re-adopted comedonecrosis as GP5, also if found in intraductal carcinoma. It is well-established that presence of GP5 conveys an unfavourable prognosis for the patient with regards to risk of lymph node and distant metastasis as well as death of disease. However, there is a paucity of data on the prognostic impact of individual GP5 sub-patterns. In biopsies the frequency of diagnosis of GP5 is about 1-5% in most published series and the most common GP5 sub-pattern is single files and single cells. In an institutional biopsy review study we noted an increase in GP5 diagnosis over time which could not be attributed to the adoption of new GP5 sub-patterns or to overdiagnosis, but might be associated with changing biopsy indications. Further studies on the prognostic impact of GP5 sub-patterns and their molecular genetic profile are indicated.
自格里森分级系统问世以来,已经进行了多次修改,包括定义格里森模式 5(GP5)及其在活检和前列腺切除术标本中的报告。这包括随着时间的推移增加了一些 GP5 亚模式,如单行、实心圆柱体和假玫瑰状。坏死性粉刺也被采用为 GP5 模式,但 2014 年国际泌尿病理学会(ISUP)将伴有坏死性粉刺的导管内癌排除在 GP5 亚模式之外,尽管绝大多数伴有坏死性粉刺的病例实际上代表导管内癌。2019 年前列腺癌分级会议重新将坏死性粉刺纳入 GP5,即使在导管内癌中也是如此。众所周知,GP5 的存在与患者的淋巴结和远处转移以及疾病死亡的风险有关,预后不良。然而,关于个别 GP5 亚模式的预后影响的数据很少。在活检中,大多数发表的系列中 GP5 的诊断频率约为 1-5%,最常见的 GP5 亚模式是单行和单细胞。在一项机构活检回顾性研究中,我们注意到 GP5 的诊断随着时间的推移而增加,这不能归因于新的 GP5 亚模式的采用或过度诊断,而可能与活检指征的变化有关。进一步研究 GP5 亚模式及其分子遗传特征的预后影响是必要的。